Susquehanna International Group’s Heart Test Laboratories HSCS Stock Holding History

Susquehanna International Group’s Portfolio HSCS Stock Details HSCS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q2	–	Sell	-492	Closed	-$5.75K	–	12538
2024 Q1	$5.75K	Buy	+492	New	+$6.43K	﹤0.01%	11950

Other funds holding HSCS

UBS Group Zurich, Switzerland $666B AUM 30.12% 1-Year Est. Return

Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $3.85B AUM 32.11% 1-Year Est. Return

Cultivar Capital Denton, Texas $155M AUM 16.34% 1-Year Est. Return

OLVIG

Oliver Lagore Vanvalin Investment Group Flint, Michigan $255M AUM

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return

Susquehanna International Group's HSCS Position: Q2 2024 in Review

Susquehanna International Group sold out of Heart Test Laboratories (HSCS) in Q2 2024, closing a stake of 492 shares — an estimated $5.75K sold.

Susquehanna International Group first reported a position in HSCS in Q1 2024 and held it in 1 quarter. The position peaked at $5.75K in Q1 2024. 7 funds tracked by Wall St. Rank hold HSCS as of Q2 2024.

Susquehanna International Group reported no remaining Heart Test Laboratories position as of Q2 2024 after selling out during the quarter.
Susquehanna International Group sold 492 Heart Test Laboratories shares in Q2 2024, an estimated $5.75K.
Susquehanna International Group first reported a position in Heart Test Laboratories in Q1 2024 and held it in 1 quarter.
Susquehanna International Group's Heart Test Laboratories position peaked at $5.75K in Q1 2024.
7 funds tracked by Wall St. Rank held Heart Test Laboratories as of Q2 2024.

Based on Susquehanna International Group's 13F filing for Q2 2024, filed 15 Aug 2024.